Pharmacist reporting of serious adverse drug events to the Food and Drug Administration

Journal of the American Pharmacists Association

Volumn 52, Issue 5, 2012, Pages

  Gavaza, Paul ^a   Brown, Carolyn M ^b   Lawson, Kenneth A ^b   Rascati, Karen L ^b   Steinhardt, Mary ^b   Wilson, James P ^b  

^a Appalachian College of Pharmacy   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Adverse drug event reporting; Adverse drug events; Community pharmacy; Hospital pharmacy; Patient safety; Pharmacovigilance

Indexed keywords

ARTICLE; AWARENESS; CLINICAL ARTICLE; COMPENSATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; INFORMATION PROCESSING; KNOWLEDGE; MALE; MEDICAL HISTORY; PATIENT ASSESSMENT; PATIENT COUNSELING; PATIENT SAFETY; PHARMACIST ATTITUDE; PILOT STUDY; UNITED STATES; BEHAVIOR; HEALTH PERSONNEL ATTITUDE; HOSPITAL PHARMACY; PHARMACIST; PHARMACY; PSYCHOLOGICAL ASPECT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ATTITUDE OF HEALTH PERSONNEL; COMMUNITY PHARMACY SERVICES; FEMALE; HUMANS; INTENTION; MALE; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84874405411     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2012.11260     Document Type: Article

References (29)

1. Arnaiz JA, Carne X, Riba N, et al. The use of evidence in pharmacovigilance: case reports as the reference source for drug withdrawals. Eur J Clin Pharmacol. 2001;57:89-91.
2. Wysowski DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch Intern Med. 2005;165:1363-9.
3. Institute of Medicine. To err is human: building a safer health system. Washington, DC: National Academies Press; 2000.
4. Barach P, Smith BJ. Reporting and preventing medical mishaps: lessons from non-medical near miss reporting system. BMJ. 2000;320:759-63.
5. Scott H, Rosenbaum S, Waters W, et al. Rhode Island physicians' recognition and reporting of adverse drug reactions. R I Med J. 1987;70:311-6.
6. van der Heijden PG, van Puijenbroek EP, van Buuren S, van der Hofstede JW. On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios. Stat Med. 2002;21:2027-44.
7. Inman WH. Detection and investigation of adverse drug reactions. In: Davies DM, Ed. Textbook of adverse drug reactions. 3rd ed. Oxford, U.K.: Oxford University Press; 1989:49-62.
8. Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf. 2000;23:165-72.
9. Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharm Drug Saf. 2007;16:223-8.
10. Cosentino M, Leoni O, Banfi F, et al. Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district. Pharmacol Res. 1997;35(2):85-8.
11. Bäckström M, Mjörndal T, Dahlqvist R, et al. Attitudes to reporting adverse drug reactions in northern Sweden. Eur J Clin Pharmacol. 2000;56:729-32.
12. Biriell C, Edwards RI. Reasons for reporting adverse drug reactions: some thoughts based on an international review. Pharmacoepidemiol Drug Saf. 1997;6:21-6.
13. Vallano A, Cereza G, Pedros C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60:653-8.
14. Bateman DN, Sanders GL, Rawlins MD. Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmacol. 1992;34:421-6.
15. Wu J-H, Shen W-S, Lin L-M, et al. Testing the technology acceptance model for evaluating healthcare professionals' intention to use an adverse event reporting system. Int J Qual Health Care. 2008;20:123-9.
16. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice Hall; 1980.
17. Patton MQ. Qualitative evaluation and research methods. 2nd ed. Thousand Oaks, CA: Sage; 1990.
18. FowlerFJ Jr. Survey research methods. 2nd ed. Thousand Oaks, CA: Sage; 1993.
19. Montano D, Kasprzyk D. The theory of reasoned action and the theory of planned behavior. In: Glanz K, Rimer BK, Lewis FM, Eds. Health behavior and health education: theory, research and practice. 3rd ed. San Fransisco, CA: John Wiley & Sons; 2002:67-98.
20. Kuyper AR. Patient counseling detects prescription errors. Hosp Pharm. 1993;28:1180-1, 1184-9.
21. Green CF, Mottram DR, Rowe PH, et al. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51:81-6.
22. Knapp KK, Quist RM, Walton SM, et al. Update on the pharmacist shortage: national and state data through 2003. Am J Health Syst Pharm. 2005;62:492-9.
23. Gidman WK, Hassell K, Day J, et al. The impact of increasing workloads and role expansion on female community pharmacists in the United Kingdom. Res Soc Admin Pharm. 2007;3:285-302.
24. Irujo M, Beitia G, Bes-Rastrollo M, et al. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish Region. Drug Saf. 2007;30:1073-82.
25. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32:19-31.
26. Figueiras A, Herdeiro MT, Polonia J, et al. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. J Am Pharm Assoc. 2006;296:1086-93.
27. Backstrom M, Mjorndal T, Dahlqvist R. Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepidemiol Drug Saf. 2002;11:647-50.
28. Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29:385-96.
29. Green EC. The WHO forum on traditional medicine in health systems, Harare, Zimbabwe, February 14-18, 2000. J Altern Complement Med. 2000;6:379-82.